Recent investigations have generated significant interest in 1-Propionyl-LSD, a comparatively little-known copyright molecule. Often considered a prodrug of LSD, 1-Propionyl-LSD seems to present a conceivably altered experience compared the parent compound. Investigators are diligently working its chemical profile and prospective clinical benefits,